INTRODUCTION
Major depression is not only a serious and highly prevalent disorder, its typical course is recurrent or chronic (Ormel et al. 1990; Judd, 1997 ; Lin et al. 1999; Mueller et al. 1999; Simon, 2000 ; Solomon et al. 2000; van den Brink et al. 2001 ; Spijker et al. 2002) . It has been estimated that more than 50% of clinically depressed patients will have another episode within 10 years and that those who have experienced two episodes have an almost 90% chance of experiencing a third. Once the disorder becomes recurrent, rates of relapse may be as high as 40 % within 4 months after recovery (Keller, 1994) . In around 20 % of cases depression becomes a chronic disorder (Spijker et al. 2000 (Spijker et al. , 2002 van den Brink et al. 2001) .
In The Netherlands, the majority of depressed individuals are initially seen by their primary care physician (PCP) and most of them continue to be treated in primary care (Spijker et al. 2001 ; Meijer et al. 2003; van der Linden et al. 2004) . Characteristic of the Dutch health-care system is the open and unlimited access to a PCP, the longitudinal continuity of the patient-PCP relationship and the gatekeeper role of the PCP, who controls access to specialist health care for somatic as well as psychiatric conditions. Effective treatments for depression, including pharmacological, psychotherapeutic and supportive approaches, are available in primary care (van Marwijk et al. 1994 (van Marwijk et al. , 2003 . However, given the often recurrent course of depression, the limited possibilities for providing adequate follow-up care and maintenance treatment in the primarycare setting give reason for concern Ludman et al. 2003) .
In the present paper, we report results on short-term effectiveness of enhanced treatment in primary care on : duration of the index episode, time to remission, recovery rates and the percentages of patients free of any depressive symptoms after 6 months. Core elements of the Depression Recurrence Prevention (DRP) program (Tiemens et al. 1998 ) include patient education, three visits with a prevention specialist and provider-initiated follow-up care, consisting of monitoring of depressive symptoms and treatment adherence by telephone and mail. Effects of this enhanced care on the course of depression and health-care use (including the use of AD medication) are compared with effects of the care usually provided for depression. Moreover, we evaluate whether the addition of a psychiatric consultation or brief cognitive behavior therapy to the basic format of the DRP program, has any surplus effects.
METHOD
The DRP program was tested in a pragmatic type randomized trial contrasting four conditions : (1) care as usual (CAU), (2) the DRP program, (3) the DRP program plus psychiatric consultation (PC+DRP), (4) the DRP program plus brief cognitive behavioral therapy (CBT+ DRP).
Setting
The settings for this study were PCP practices in and around the city of Groningen, in the northern part of The Netherlands. The selection of PCPs was primarily guided by pragmatic principles and circumstances, such as availability, the location of the practice, the number of physicians sharing a practice and participation in earlier studies by the department. No formal criteria applied for the inclusion. Participating PCPs were invited to attend a 2-hour booster session about guidelines for the treatment of depression in general practice (van Marwijk et al. 1994 ; Jenner et al. 1995; Schulberg et al. 1998) . During these group meetings the risk of depression turning into a recurrent or chronic illness was emphasized and implications for management in primary care were discussed.
Patients
Main inclusion criterion was a current (i.e. present in the past 2-12 weeks) diagnosis of major depression according to DSM-IV criteria. We excluded patients younger than 17 years and older than 70 years of age, patients suffering from a life-threatening medical condition, a psychotic disorder, dementia, and those with a primary addiction to alcohol or psychotropic drugs. In addition, women who were pregnant or nursing and patients already receiving treatment for depression elsewhere (i.e. by a psychiatrist, psychologist or social worker) were excluded.
Inclusion of patients was by a three stageprocedure. First, participating PCPs were asked to refer any patient whom they considered to be depressed. Referral was based on the PCP's assessment on a brief symptom checklist on which the DSM-IV criteria for major depression were summarized ; the checklist was provided by the project. In the second stage research assistants contacted the patients by telephone to establish study eligibility. For confirmation of the PCP depression diagnosis we used a brief screening instrument, containing the stem items for major depression and dysthymia from the Composite International Diagnostic Interview (CIDI ; WHO, 1997) . Patients fulfilling study entry criteria were provided with detailed information on the study, verbally and in writing, in order to obtain their consent. Patients agreeing to enter the third step in the inclusion procedure -thereby stating their willingness to be randomized -were interviewed face to face with the computerized lifetime version of the CIDI. With this interview the final diagnosis leading to inclusion or exclusion was reached. If the diagnosis was positive for depression the patient entered the randomization procedure.
Randomization procedure and treatment assignment Randomization took place immediately at the baseline appointment. We used a randomized design stratified for use of antidepressants (AD : yes/no) at baseline. Within each stratum, patients were assigned to one of four conditions by means of a computer-generated random allocation list.
Once the diagnosis of major depression was confirmed by CIDI, the interviewer contacted a research assistant by telephone. This assistant, who had had no prior personal contact with the patient, opened the first sealed opaque envelope from the appropriate set, representing the AD+ or ADx stratum, and passed the information on treatment allocation on to the interviewer.
For patients assigned to one of the experimental conditions time and place of the first session with the appropriate specialist were scheduled. Patients assigned to the DRP program received the educational materials (book and videotape) that are an integral part of the program. PCPs were informed about study inclusion and the outcome of randomization within 1 week of the baseline assessment.
Measures
All patients were followed up prospectively for 3 years. Research assessments were made at baseline and every 3 months thereafter. Followup interviews were conducted by telephone by trained research assistants using a laptop computer. Each follow-up included a core set of questions concerning the presence of depressive symptoms and their course over time, the use of AD medication, contacts with health-care providers and competence in daily functioning. The interviews were combined with several selfreport questionnaires every 6 months.
Depression status
At the baseline assessment, the full depression and anxiety sections of the lifetime version of the computerized CIDI (CIDI-auto ; WHO, 1997 ; Dutch version by Ter Smitten et al. 1998) were included. The CIDI is a structured diagnostic interview, with good reliability and validity (Wittchen, 1994 ; Andrews & Peters, 1998) and suitability for use in primary-care populations (Ustun & Sartorius, 1995) . We added questions on the presence of (any residual) depressive symptoms in the past 4 weeks to obtain a full symptom profile. To systematically record onset and recency of depressive symptoms in the follow-up interviews, we developed a brief, structured and computerized interview measure based on the CIDI. We examined treatment effects on duration of the index episode, time to remission, recovery rates and the percentages of patients free of any depressive symptoms after 6 months. In accordance with the consensus paper of Frank et al. (1991) and DSM-IV criteria, remission is defined as at least two consecutive weeks without depression and recovery as at least eight consecutive weeks without depression.
The Beck Depression Inventory (BDI ; Beck et al. 1961 ) is included in each follow-up to monitor depression severity. BDI scores <9 are generally seen as indicating normal, nondepressed mood states, whereas BDI scores o15 indicate a fully symptomatic depression (Beck et al. 1988 ; Frank et al. 1991) . The BDI has good psychometric characteristics (e.g. Hammen, 1997) and is also sensitive to change over time (Richter et al. 1998) .
Use of ADs, contacts with PCP and other care utilization Number of visits with the PCP and use of AD medication were recorded at each follow-up. In addition, we asked patients whether they had received help from other (mental) health providers, including ambulatory mental health care and freely established psychologists and psychiatrists in private practices.
Statistical analyses
Sample sizes were determined by power analysis. We originally hypothesized the following gradient of outcome success, expressed in percentages of patients being recovered at 6 months : in CAU 60 %, in DRP 70 %, in PC+DRP 80% of and in CBT+DRP 90%. With 62 patients in CAU, 96 in DRP, 32 in PC+DRP and 36 in CBT+DRP these outcomes would yield a Cramer's w' of 0 . 223, corresponding with a satisfactory power of 81 %.
To analyze differences between groups, we used x 2 tests for dichotomous variables and t tests or non-parametric tests (Mann-Whitney, Kruskal-Wallis) for continuous variables, depending on their distribution. Change over time in continuous outcome variables between the treatment groups was tested by means of repeated-measures ANOVAs. Where appropriate, full comparisons were supplemented with pairwise comparisons. Survival analysis, including the log rank test, was applied in comparing the treatment groups as to the time to recovery.
All analyses were based on intention to treat. In addition, completer analyses were applied where judged to be informative. We used SPSS version 12 (SPSS Inc., Chicago, IL, USA).
Interventions

DRP program
The DRP program is a structured psychoeducational intervention, based on an ongoing relationship between the patient, a prevention specialist and the PCP. The primary goal is to reduce depression recurrence. The intervention is aimed at increasing patients' self-efficacy with regard to coping with depressive symptoms, extending the potential of pro-active measures and stress-management strategies and skills to identify relapse or recurrence early on. The focus is on improving patients' resilience and self-management skills (Smit et al. 2005) .
The program consists of three individual face-to-face sessions with a trained prevention specialist, followed by four telephone monitoring contacts per year for a 3-year period. Prior to the first session, patients receive a book and corresponding videotape on depression, treatment options, relapse prevention and self-management strategies. At the last face-toface session, depression specialist and patient prepare a patient-tailored depression prevention plan, with the following topics : regular self-registration of early warning signs ; stress reduction strategies ; an 'emergency plan ' ; and a medication plan, for patients using ADs. A copy of this plan is sent to the PCP. Main goals of the standardized three-monthly followup contacts are to systematically monitor depressive symptoms, review patient progress and to provide feedback and support. Motivational interviewing (Miller & Rollnick, 2002 ) is used to enhance confidence in the patient's ability to succeed, to support self-efficacy and strengthen commitment to the program over time.
One psychiatric nurse and two psychologists, all females, were trained by two experts from the Seattle project to deliver the enhanced treatment program. Adherence to the DRP protocol was monitored in regular supervision sessions with a psychiatrist who had also attended the training. The prevention specialists used standardized forms for each patient contact. During the first phase, they provided the PCP with written feedback of each session, and in the follow-up phase they kept a record of all patient contacts.
The intervention was developed by Katon and co-workers at the Center for Health Studies of the University of Washington in Seattle, USA (Katon et al. 1996; Ludman et al. 2000) and adapted for use in The Netherlands by Tiemens and colleagues (Tiemens et al. 1998) . For a more detailed description we refer to Smit et al. (2005) .
PC+DRP program
Patients in the PC+DRP group were offered one 1-hour visit with one of two available psychiatrists, prior to the DRP program. The PCP provided the psychiatrist with information about the patients' health and treatment status. Afterwards, the psychiatrist reported his diagnostic findings and treatment advice to the PCP. A copy of this written report was also made available to the prevention specialist. The main purpose of the psychiatric consultation was to make more specific psychiatric expertise on diagnosis and pharmacological treatment of depression available for use in primary-care practice.
CBT+DRP program
The CBT+DRP group was offered 10-12 individual weekly 1-hour sessions of CBT treatment, tailored to primary care by Boelens (1997) . The DRP program started after the final CBT session. The CBT therapist informed the prevention specialist about the main themes that the CBT had addressed and the progress achieved.
Three qualified CBT therapists were employed. To reinforce concepts and CBT techniques and to monitor their adherence to the protocol, regular supervision sessions were held. The acting supervisor was the regional CBT expert who developed the treatment protocol.
The main purpose of including CBT was that this has been found to be an effective treatment for depression and there are indications that CBT may reduce relapse rates (Fava et al. 1998; Paykel et al. 1999; Scott et al. 2000) . However, studies on CBT in primary-care patients are scarce and results are not consistent (see Scott et al. 1997; Ward et al. 2000) .
CAU
Patients assigned to the usual care group were referred back to their own PCP and received the care that this PCP deemed appropriate. In most cases, this included a combination of AD medication and counseling during regular visits (van Os et al. 1999 ). As in current practice PCPs were free to refer patients to any service normally available, such as social workers, private practice psychiatrists or psychologists, or specialized mental health agencies.
RESULTS
PCPs
A total of 55 PCPs in the northern part of The Netherlands agreed to participate. The mean number of patient referrals per PCP was 7 . 2, but there were considerable differences between PCPs in this respect (range 1-43) ; 13 PCPs (24 %) referred 10 or more patients. The mean number of included patients per PCP was 5 . 5 (range 1-35) ; of eight PCPs, 10 or more patients were included. The final study group consists of 267 patients from 49 PCPs.
Patients
Of 397 patients who were identified as depressed by their PCP and referred to the study, 323 (81 . 4 %) agreed to the screening procedure. The majority (n=277, 85 . 8%) was eligible and willing to take part in the study (see Fig. 1 ). On the baseline assessment 10 patients were excluded because they did not fulfill study entry criteria. Thus, a total of 267 patients, comprising 67 % of all initially referred patients and 83% of those who could be contacted and screened, met the inclusion criteria and were randomly assigned to one of the four treatment conditions. 72 patients (27 %) were assigned to CAU and 195 patients were assigned to the enhanced care program : 112 patients (57 %) were offered the DRP program only, 39 patients (20 %) were assigned to PC+DRP and another 44 patients (23 %) were assigned to the brief CBT followed by DRP.
The percentages of respondents at the follow-up were 90 % after 3 months and 85 % after 6 months. These rates were similar between treatment groups.
Baseline characteristics
In Table 1 , sociodemographic and clinical characteristics of the baseline sample are summarized. Randomization proved to be successful ; there were no significant differences on any of these characteristics between patients in the four treatment groups.
Patient acceptance of treatment assignment
Overall, 92 % of the intervention patients attended all three individual face-to-face sessions with a depression prevention specialist; 94% attended at least one. Participation in this phase was highest among patients randomized to the DRP program only (96 %) and in those assigned to PC+DRP (97 %), but lower in the group where DRP followed after CBT (75 %; x 2 =23 . 97, df=2, p<0 . 0001). In the 6 months after the last session, prevention specialists remained in contact with the vast majority of the patients, with 98 % returning their mail and responding to both of the telephone calls.
With regard to the additional treatments by mental health specialists, all 39 patients randomized to PC+DRP agreed to the visit with the psychiatrist. In comparison, compliance with CBT was lower : 33 of the 44 patients assigned to CBT completed this treatment (75 %), while three patients refused and eight dropped out prematurely (after a mean of four sessions).
Depression outcome
As shown in Table 2 , we found no evidence that enhanced care was more effective than CAU in the short term. After 27 weeks the recovery rate was 66% and similar among CAU and enhanced care patients. A total of 17 % of study participants remained depressed during this entire period.
Time to recovery
The mean duration of the index depressive episode was 11 weeks (S.D.=9 . 78) and similar in CAU and enhanced care patients (see Fig. 2 ).
Depression severity (BDI)
BDI scores improved the most in the first 3 months (on average 6 . 81 points), and the percentage of patients scoring above the threshold (BDI o15) fell from 69 % to 38 % overall at the 6-month follow-up. We found Recovery, no diagnosis for at least 8 weeks. Remission, no diagnosis, lasting 2-7 weeks. No statistically significant differences (p<0 . 05). We also performed additional pairwise comparisons (no statistically significant differences ; results available on request). no statistically significant differences in the comparisons between treatment groups.
Treatment : AD medication and additional health-care use At the 3-month follow-up, AD use was significantly lower in patients assigned to CBT+DRP, compared with CAU and both other DRP groups (Table 3 ). At the 6-month follow-up, AD use in CBT patients remained significantly lower compared with that of PC+DRP patients. The majority of patients remained in touch with their PCP during the first 6 months, but this proportion was lowest in the CBT+DRP group. Additional mental health-care use was different for CAU and enhanced care patients, with CAU patients receiving more specialist mental health care by freely established psychologists, ambulatory mental health-care or social workers. In the period between the 3-and 6-month follow-up, when most enhanced care patients finished the first phase of the DRP program, the number of DRP patients receiving other mental health-care also rose.
DISCUSSION
The DRP program aims at integrating treatment for the acute episode and the prevention of depression relapse and recurrences. Patients included in this trial suffered from recurrent depression. The short-term outcome data presented in this paper reflect initial response to treatment and show hardly any contrasts between the CAU and enhanced care patients. Several explanations should be considered for this lack of difference.
Foremost of course, the DRP program and its combinations with either a psychiatric consultation or brief CBT may not have been capable or powerful enough to add to the effects already achieved by usual care. We saw high depression treatment rates in CAU, especially in the interval between study inclusion and the 3-month follow-up, which may mean that most patients already received optimal and guidelineconcordant treatment from their PCP.
At baseline, AD use was almost 75 % overall. At follow-up, medication adherence rates in the CAU, DRP and PC+DRP patients were higher than anticipated. Although poor compliance with drug treatment is frequently reported as a problem (Pampallona et al. 2002) , especially in primary care (Lawrenson et al. 2000) , this did not seem to be the case in the present study. Thus, with the exception of CBT+DRP (there was no specific focus on medication compliance in the CBT protocol), rates of both initial AD use as well as adherence are higher than found in previous primary-care studies. This may be explained in several ways. First, relevance of medication adherence was a subject dealt with explicitly in the DRP program. Second, because of the experience of multiple episodes, patients may have been more willing to accept AD continuation treatment for their present episode. Third, AD treatment seems to have become a more routine practice in Dutch primary-care settings. Data from national studies show that PCPs are responsible for the majority (78 %) of prescriptions for ADs in The Netherlands and that the number of these prescriptions has increased substantially year by year (van Marwijk et al. 2001; CVZ, 2003) . Laurant and colleagues (2004) report that in 68% of PCP-diagnosed depressive episodes an AD was prescribed. Furthermore, the majority of patients in our study visited their PCP regularly. Data on PCP prescribing behavior demonstrates that the increase in AD prescriptions occurred mainly during repeat consultations (van Marwijk et al. 2001; van Os et al. 2002) . In addition, recent findings confirm that AD adherence among primary-care patients seems to have become less problematic. Brook and co-workers (2005) studied the effects of a pharmacy-based program on improving adherence to AD treatment in primary care and found 6-month adherence rates of 73 % in CAU (and 76% in the experimental group).
The referral rates to specialized mental health care also deserve attention. The fact that during the first 6 months more than one third of CAU patients received some form of specialist care may have been a side-effect of the study, in two ways : (1) a number of PCPs may have 'used ' the selection procedure primarily for diagnostic purposes, i.e. to get their suspicions confirmed ; once this happened they may have seen referral of the patient as the most appropriate reaction; (2) patients assigned to usual care may have been disappointed by this randomized assignment and sought treatment elsewhere, whether or not by formal referral. However, these figures may also reflect the growing tendency in
The Netherlands for PCPs to refer patients with a psychological diagnosis to more specialized mental health agencies, including privatepractice psychologists (Verhaak et al. 2000 ; Meijer et al. 2003) .
After finishing the first phase of the DRP program, the number of enhanced care patients receiving specialized mental health care also rose. This could have been due to the same shift described above, with more patients being referred. Patient preferences may also be of importance, since available studies show that many patients prefer psychotherapy in the treatment of depressive disorders (van Schaik et al. 2004) . Furthermore, given that most patients had already experienced more episodes, lack of confidence in their own abilities to successfully overcome depression and prevent future episodes may also explain this helpseeking behavior. We found indications for a persistent lack of self-confidence in dealing with depression in 3-month follow-up scores on a self-efficacy questionnaire (DSES ; Bush et al. 2001) , where scores remained low overall and there was no evidence that enhanced care patients benefited more from their treatment than patients receiving CAU (Smit et al. 2005) . 
Strengths and limitations
Our study has several strengths. Since the aim is to find information on the effectiveness of the intervention, patient inclusion criteria were not very stringent. This permitted the majority (83 %) of patients who where screened after being referred by their PCP to enter the trial. Also, more than 50 PCPs were willing to participate. Several researchers (Fairhurst & Dowrick, 1996 ; Hunt et al. 2001) have found this kind of participation hard to achieve. Randomization was successful, with similar demographic and clinical characteristics in all four arms of the study. Acceptance of the interventions was high. CBT and PC are common referral options for treatment of depression, which increases the relevance of our findings for primary-care practice. Our method of establishing depression status at each followup enabled us to systematically record current symptoms week by week, follow the course of existing symptoms and trace the onset of 'new ' ones. Last, but certainly not least, follow-up response rates were good. By definition, conducting a pragmatic trial implies that several factors are beyond the control of the researchers. Participating PCPs were free to manage the CAU and enhanced care patients as they saw fit. We did not influence or determine their treatment decisions. Referral rates for CAU patients seemed high, although we now find that they may also reflect current primary-care practice. Selection of the PCPs was not random, and participating PCPs may have been more interested in the subject of depression treatment and relapse prevention than the average PCP. Patient recruitment was slower than anticipated and we needed more time than originally planned to enroll enough patients. During this recruitment period, lasting 3 . 5 years in total, the observed changes in referral behavior and the prescription of ADs may have become more routine practice for depression management by PCPs. Another limitation is that, while the study had sufficient power to test the gradient of the outcomesuccess hypothesis, pairwise comparisons of the PC and CBT arms with CAU or DRP are probably underpowered. There appeared to be a trend towards more positive outcomes in the PC+ DRP group, but on the other hand, observed differences were small and it can be questioned whether they are clinically relevant. Finally, it was not possible to blind interviewers from the treatment status of the participants.
CONCLUSION
Although well-received and appreciated by patients and PCPs, we found no evidence that the DRP program was more effective than CAU in the short term. Three and 6 months into the trial period, we found similar depression rates in enhanced care and CAU patients, but it should be noted that depression treatment rates in CAU were high. In addition, we found hardly any indications for added beneficial effects of either the psychiatric evaluation or the CBT treatment to the basic format of the DRP program. Thus, enhanced care did not result in better depression outcomes in the short term. However, given that the follow-up care provided in the context of the DRP program continues for 3 years, it might be that benefits of this enhanced care over CAU will only become clear after a more prolonged period.
